Introduction Greetings from CEO

Greetings from CEO

We will help our clients succeed with our two wings of bio translation capabilities and CRO consulting services!
Thanks to the support of our valued customers, we have firmly established ourselves as a specialized bio-translation company.


A Company Specialized in Providing Professional Translation/Correction Services for Pharmaceutical Companies, CROs, Medical Equipment, and Clinical Trials.
A Company recognized by over 80 domestic universities including SNU, Yonsei University, and Korea University as well as over 500 Research Institutions
Mistranslation can happen even in communications on national level such as the case of FTA between Korea and U.S.A.
Enterprises which are aiming for global markets and customers need best translation service provider...


Over the past decade, ENCO-Pharm has grown steadily as a specialized translation company in the field of biotechnology, thanks to the support of our valued customers.
The biotech industry has experienced remarkable growth and development not only overseas but also in Korea. Consequently, there has been a rapid increase in demand for translation of various documents in the biotech field. Despite this surge in demand, finding a translation company with specialized professionals in this field has not been easy in Korea. In this challenging environment, ENCO-Pharm entered the specialized area of biotech translation over a decade ago, accumulating rich practical experience and expertise. Now, we have firmly established ourselves as a distinctive specialized translation company in this field. All these achievements are thanks to the warm advice, praise, and encouragement received from our customers.
As a subsidiary of Harrisco, a leading academic paper English correction and translation company, ENCO-Pharm has grown into a specialized translation company in the biotech industry based on Harrisco's English correction and translation capabilities. Harrisco, the parent company of ENCO-Pharm, has gained a reputation as the designated translation and correction brand for over 80 universities and 250 associations, including Seoul National University, Yonsei University, Korea University, Ewha Womans University, Sogang University, Sungkyunkwan University, and Kyung Hee University. Harrisco's professional capabilities and global network have greatly contributed to ENCO-Pharm's growth as a specialized brand in biotech translation.
Recognized for delivering excellent quality in biotech translation, ENCO-Pharm has secured contracts with over 250 institutions and companies, including global CRO Quintiles, CMIC Korea, LG Life Science, Dong-ah ST, Daewoong Pharmaceutical Co., Ltd., and PharmAbcine Co., Ltd., providing translation services.

ENCO-Pharm has now expanded its business into CRO Consulting Services.


ENCO-Pharm has ventured into a new business, 'CRO Consulting,' at the beginning of the new year. Leveraging our solid capabilities and extensive global network built in the field of translation, including clinical trial services in the bio-industry, we have embarked on CRO consulting after thorough preparation.
The newly launched ENCO-Pharm CRO Consulting service aims to provide one-stop pharmaceutical R&D services from idea conception to IND (Investigational New Drug). Specifically, we plan to offer specialized services in compound synthesis, compound activity screening, structural biology, CMC (Chemistry, Manufacturing, and Controls), pharmacology evaluation, pharmacokinetics, and toxicological stability evaluation. Additionally, we will conduct comprehensive project management and submission services. ENCO-Pharm commits to delivering the same dedication and expertise that it has demonstrated in the field of bio-translation to the newly inaugurated CRO Consulting business.
Especially noteworthy is our intention to provide customized CRO services through the global networks of HarrisCo and ENCO-Pharm in the pharmaceutical and clinical fields. We will continue our unwavering efforts to contribute to the success of our customers with the dual wings of bio-translation capabilities and CRO consulting services.

Thank you.

Kim Moo-jin, President & CEO
Center for Editorial Correction of English Papers: President of HARRISCO
Editorial Correction by Native English Speakers, Courses of English Writing, Translation Services President of ENCORRECTION
Top Ranked Professional Translation Service for the Domestic Bioindustry President of ENCOPHARM